Status:
COMPLETED
Nocturnal Oxygen Therapy
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Lung Diseases, Obstructive
Eligibility:
All Genders
35-70 years
Phase:
PHASE3
Brief Summary
To compare the efficacy of long-term use of nocturnal oxygen therapy (12 hours) with that of continuous, low-flow oxygen therapy (24 hours) in patients with chronic hypoxic lung disease.
Detailed Description
BACKGROUND: Chronic obstructive pulmonary disease is a major health problem in the United States. In 1975, it was the sixth leading cause of death. The economic impact of the disease in 1972 amounted...
Eligibility Criteria
Men and women, ages 35 to 70, who had severe chronic obstructive lung disease requiring supplemental oxygen therapy.
Key Trial Info
Start Date :
July 1 1976
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000564
Start Date
July 1 1976
Last Update
June 24 2005
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.